Core Viewpoint - Egide Group is centralizing all its US manufacturing operations at its Cambridge site in Maryland, closing its Santier subsidiary in San Diego, to enhance operational efficiency and competitiveness in North America [1][2][5]. Group's Strategic Objectives - The decision to merge US operations aims to enhance industrial competitiveness by effectively absorbing fixed costs and improving resource allocation [5]. - The consolidation is expected to boost operational improvement, as Egide USA has shown strong performance driven by increasing demand for critical applications [6]. - Centralizing operations will clarify the industrial structure in North America and strengthen the technology portfolio [7]. Santier Site Closure - Business volumes at the Santier site have been declining, making it unsustainable to maintain its cost structure [8][9]. - The closure is a response to the insufficient business activity, particularly after the discontinuation of several high-value programs [8]. Transition Management - The transfer of operations to the Cambridge site will be gradual, ensuring service continuity and customer satisfaction throughout the process [10][12]. - Santier will continue to fulfill existing orders, with new orders being processed at the Cambridge site, and the closure is expected to be completed by April 2026 [11].